Avadel Pharmaceuticals (AVDL) Tax Provisions: 2009-2020
Historic Tax Provisions for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Dec 2020 value amounting to -$2.9 million.
- Avadel Pharmaceuticals' Tax Provisions rose 68.30% to -$2.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$26.4 million, marking a year-over-year decrease of 392.89%. This contributed to the annual value of -$12.1 million for FY2020, which is 126.10% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Tax Provisions of -$2.9 million as of Q4 2020, which was up 43.41% from -$5.0 million recorded in Q3 2020.
- In the past 5 years, Avadel Pharmaceuticals' Tax Provisions registered a high of $13.3 million during Q4 2016, and its lowest value of -$14.5 million during Q4 2018.
- Its 3-year average for Tax Provisions is -$3.7 million, with a median of -$2.3 million in 2018.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Tax Provisions surged by 944.34% in 2016, and later tumbled by 667.92% in 2018.
- Avadel Pharmaceuticals' Tax Provisions (Quarterly) stood at $13.3 million in 2016, then plummeted by 80.83% to $2.6 million in 2017, then tumbled by 667.92% to -$14.5 million in 2018, then skyrocketed by 38.09% to -$9.0 million in 2019, then soared by 68.30% to -$2.9 million in 2020.
- Its last three reported values are -$2.9 million in Q4 2020, -$5.0 million for Q3 2020, and -$9.5 million during Q2 2020.